Development
Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.40-40.00%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 320.49% | -21.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 323.77% | -21.04% | |||
| Operating Income | -297.95% | 17.85% | |||
| Income Before Tax | -297.95% | 17.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -297.95% | 17.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -297.95% | 17.85% | |||
| EBIT | -297.95% | 17.85% | |||
| EBITDA | -299.18% | 17.91% | |||
| EPS Basic | -300.00% | 20.00% | |||
| Normalized Basic EPS | -300.00% | 16.67% | |||
| EPS Diluted | -300.00% | 20.00% | |||
| Normalized Diluted EPS | -300.00% | 16.67% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||